CRISPR Therapeutics AG (CRSP) Prepaid Assets (2015 - 2026)

CRISPR Therapeutics AG has disclosed Prepaid Assets across 12 years of filings, most recently posting $7.4 million for Q2 2026.

• In Q2 2026, Prepaid Assets fell 40.32% year-over-year to $7.4 million; the TTM figure through Jun 2026 stood at $7.4 million (down 40.32% YoY), while the FY2025 annual figure was $9.8 million, up 18.5% from the prior year.
• Prepaid Assets came in at $7.4 million for Q2 2026 at CRISPR Therapeutics AG, up from $6.6 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $41.7 million in Q2 2022 to a low of $6.6 million in Q1 2026.
• Average Prepaid Assets over 5 years is $18.6 million, with a median of $12.9 million recorded in 2025.
• Year-over-year, Prepaid Assets tumbled 61.85% in 2023 and jumped 62.28% in 2025.
• Over 5 years, Prepaid Assets stood at $37.7 million in 2022, then plunged by 61.85% to $14.4 million in 2023, then sank by 42.26% to $8.3 million in 2024, then advanced by 18.5% to $9.8 million in 2025, then slipped by 24.64% to $7.4 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $7.4 million in Q2 2026, $6.6 million in Q1 2026, and $9.8 million in Q4 2025.